Dana Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History

Dana Investment Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.9K	Hold	20,406	–	–	﹤0.01%	572
2026 Q1	$62.6K	Hold	20,406	–	–	﹤0.01%	556
2025 Q4	$72.6K	Hold	20,406	–	–	﹤0.01%	551
2025 Q3	$182K	Buy	20,406 +8,551	+72%	+$86.7K	0.01%	555
2025 Q2	$109K	Hold	11,855	–	–	﹤0.01%	535
2025 Q1	$102K	Hold	11,855	–	–	﹤0.01%	538
2024 Q4	$127K	Hold	11,855	–	–	﹤0.01%	537
2024 Q3	$67.3K	Hold	11,855	–	–	﹤0.01%	531
2024 Q2	$50K	Hold	11,855	–	–	﹤0.01%	522
2024 Q1	$60.3K	Hold	11,855	–	–	﹤0.01%	522
2023 Q4	$110K	Hold	11,855	–	–	0.01%	419
2023 Q3	$77.7K	Hold	11,855	–	–	﹤0.01%	405
2023 Q2	$96.4K	Buy	11,855 +1,170	+11%	+$10K	﹤0.01%	390
2023 Q1	$91.6K	Hold	10,685	–	–	﹤0.01%	395
2022 Q4	$98.9K	Hold	10,685	–	–	0.01%	398
2022 Q3	$110K	Hold	10,685	–	–	0.01%	390
2022 Q2	$107K	Hold	10,685	–	–	0.01%	404
2022 Q1	$132K	Buy	+10,685	New	+$131K	0.01%	337

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dana Investment Advisors's AVXL Position: Q2 2026 in Review

Dana Investment Advisors held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 20,406 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Dana Investment Advisors first reported a position in AVXL in Q1 2022 and has held it in 18 quarters since. The position peaked at $182K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Dana Investment Advisors held 20,406 shares of Anavex Life Sciences worth $52.9K as of Q2 2026.
Dana Investment Advisors left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of Dana Investment Advisors's portfolio in Q2 2026, its #572 holding.
Dana Investment Advisors first reported a position in Anavex Life Sciences in Q1 2022 and has held it in 18 quarters since.
Dana Investment Advisors's Anavex Life Sciences position peaked at $182K in Q3 2025.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.